Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Allergan Inc/United States

+ Add to Watchlist

AGN:US

232.7400 USD 0.3400 0.15%

As of 20:04:05 ET on 02/27/2015.

Snapshot for Allergan Inc/United States (AGN)

Open: 232.0600 Day's Range: 232.0000 - 233.5000 Volume: 2,553,122
Previous Close: 232.4000 52wk Range: 115.9400 - 234.6800 1-Yr Rtn: +83.46%

Stock Chart for AGN

No chart data available.
  • AGN:US 232.7400
  • 1D
  • 1M
  • 1Y
232.4000
Interactive AGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AGN

Current P/E Ratio (ttm) 37.2541
Estimated P/E(12/2015) 26.8412
Relative P/E vs. SPX 2.1346
Earnings Per Share (USD) (ttm) 6.2474
Est. EPS (USD) (12/2015) 8.6710
Est. PEG Ratio 1.5338
Market Cap (M USD) 71,592.19
Shares Outstanding (M) 307.61
30 Day Average Volume 2,018,373
Price/Book (mrq) 8.9828
Price/Sale (ttm) 9.5712
Dividend Indicated Gross Yield 0.09%
Cash Dividend (USD) 0.0500
Dividend Ex-Date 02/25/2015
5 Year Dividend Growth 0.00%
Next Earnings Announcement 05/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AGN

Allergan, Inc. is a multi-specialty health care company that develops and commercializes pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets globally.

David E I PyottChief Executive OfficerDouglas S IngramPresident
Arnold A PinkstonExec VP/Gen Cnsl/Asst SecyJames M Hindman "Jim"Exec VP:Finance & Bus Dev/CFO
More Company Profile & Key Executives for AGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil